Status:
COMPLETED
Pseudoexfoliation Syndrome, Sarcopenia and Chronic Pain
Lead Sponsor:
Eskisehir Osmangazi University
Conditions:
Sarcopenia
Pseudoexfoliation Syndrome
Eligibility:
All Genders
60+ years
Brief Summary
Aim: Pseudoexfoliation syndrome (PEX) is a systemic disease of connective tissue, it can also contribute to sarcopenia and chronic musculoskeletal pain with common pathways. 1. First aim of this stud...
Detailed Description
Sarcopenia is defined as a decreased muscle mass, muscle strength and muscle function, which leads to lower physical performance, disability and quality of life. Pseudoexfoliation syndrome (PEX) is an...
Eligibility Criteria
Inclusion
- Being over 60 years
- Undergoing a detailed complete ophtalmic examination by an experienced physician within 1 month at the Department of Ophtalmology in the same university hospital.
Exclusion
- having ophtalmic diseases that cause vision loss and reduce quality of life and mobility smoking, acute/subacute pain, amputation, infection, active arthritis, active cancer, having any protesis or surgery in lower extremities and low back, neurological disorders, malabsorption, weight loss, uncontrolled major systemic diseases, impaired cognitive function and being immobilised.
Key Trial Info
Start Date :
March 30 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 25 2023
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT06121154
Start Date
March 30 2023
End Date
October 25 2023
Last Update
November 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eskişehir Osmangazi University
Eskişehir, Turkey (Türkiye)